InnoJin is a Juntendo University–origin startup using digital technology to research, develop, approve, and commercialize medical-device solutions aimed at medical DX. Its main product, AllerSearch, is a smartphone app that quantifies pollen allergy levels via eye‑image redness analysis and questionnaires and suggests allergy types and countermeasures. AllerSearch also offers a real‑time “everyone’s pollen map” so users can view regional pollen‑allergy conditions to support self‑medication and reduce healthcare costs. The company also offers DryEyeRhythm, a smartphone app for quick dry‑eye checks that lets users evaluate symptoms and supports early detection, prevention, and treatment. A study published in August 2023 showed equivalence between the app’s electronic dry‑eye questionnaire and the conventional paper version, supporting use in remote and online care. InnoJin plans to use new funding to accelerate clinical research and trials for market introduction and to strengthen its organizational base.

Total raised

$3M

Funding rounds

1

Latest round

Series B

Latest activity

Mar 2024